Among other actions:
Sold subsidiary, stellacure, GmbH ("stellacure") to Medivision mbH
Launched new service offering for the storage of mesenchymal cells through its wholly owned subsidiary CorCell Companies, Inc.
Achieved AABB accreditation for cell therapy activity associated with cord blood processing, storage and distribution.
Sold its 50.004% ownership stake in Argentina based Biocordcell Argentina, S.A. (Bio) to Diego Rissola, which lost money and was a cash drain.
Executed a purchase agreement for the sale of $0.724 million preferred equity investment funded by Red Oak Partners, LLC and its affiliates ("Red Oak"). All proceeds used towards retiring debt owed to Tonaquint, Inc. ( completed).
Eliminated MATT'S dealings, but
Best of all kicked out big bad Matt and the Mrs.
